Cumberland County v. Purdue Pharma LP et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:19-op-45259 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1331 Fed. Question: Personal Injury |
| Case Filed: | Apr 16, 2019 |
| Case in other court: | Maine, 2:19-cv-00093 |
| Last checked: Friday Nov 08, 2019 7:30 PM EST |
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Walmart Inc.
|
Represented By
|
|
Defendant
Walgreens Boots Alliance Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Rite Aid of Maryland, Inc.
|
Represented By
|
|
Defendant
Rite Aid of Maine, Inc.
|
Represented By
|
|
Defendant
Rite Aid Corporation
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Purdue Pharma Inc
|
Represented By
|
|
Defendant
Purdue Frederick Company
|
Represented By
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Mallinckrodt Enterprises LLC
|
Represented By
|
|
Defendant
Douglas J. Jorgensen
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Insys Therapeutics Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Mark E. Cieniawski
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Cardinal Health 110, LLC
|
Represented By
|
|
Defendant
CVS Pharmacy Inc.
|
Represented By
|
|
Defendant
Michael B. Bruehl
|
Represented By
|
|
Defendant
AmerisourceBergen Drug Corporation
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
Allergan Finance LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Plaintiff
Cumberland County
|
Represented By
|
| Docket last updated: 06/24/2019 5:01 PM EDT |
| Friday, March 01, 2019 | ||
| 1 | 1
NOTICE OF REMOVAL from Cumberland County Superior Court, case number CV-19-19. PAYMENT OF FILING FEE DUE WITHIN 48 HOURS. IF FILING FEE IS BEING PAID WITH A CREDIT CARD COUNSEL ARE INSTRUCTED TO LOGIN TO CMECF AND DOCKET Case Opening Filing Fee Paid FOUND IN THE Complaints and Other Initiating Documents CATEGORY. CHECK PAYMENTS DUE WITHIN 48 HOURS. , filed by AMERISOURCEBERGEN DRUG CORPORATION. (Service of Process Deadline 5/30/2019) Fee due by 3/4/2019.(bfa) [Transferred from med on 4/16/2019.]
|
|
|
Att: 1
Declaration of Joshua D. Dunlap,
|
||
|
Att: 2
Complaint,
|
||
|
Att: 3
Demand Letter to Actavis LLC,
|
||
|
Att: 4
Demand Letter to Actavis Pharma, Inc,
|
||
|
Att: 5
Demand Letter to Allergan plc,
|
||
|
Att: 6
Demand Letter to Allergan plc,
|
||
|
Att: 7
Demand Letter to AmerisourceBergen Drug Corporation,
|
||
|
Att: 8
Demand Letter to Dr. Bruehl,
|
||
|
Att: 9
Demand Letter to Cardinal Health 101, LLC,
|
||
|
Att: 10
Demand Letter to Cephalon, Inc,
|
||
|
Att: 11
Demand Letter to Dr. Cieniawski,
|
||
|
Att: 12
Demand Letter to Endo Health Solutions Inc,
|
||
|
Att: 13
Demand Letter to Endo Pharmaceuticals, Inc,
|
||
|
Att: 14
Demand Letter to Insys Therapeutics, Inc,
|
||
|
Att: 15
Demand Letter to Janssen Pharmaceutica, Inc,
|
||
|
Att: 16
Demand Letter to Janssen Pharmaceuticals, Inc,
|
||
|
Att: 17
Demand Letter to Johnson & Johnson,
|
||
|
Att: 18
Demand Letter to Dr. Jorgensen,
|
||
|
Att: 19
Demand Letter to Mallinckrodt Enterprises LLC,
|
||
|
Att: 20
Demand Letter to McKesson Corporation,
|
||
|
Att: 21
Demand Letter to Ortho-McNeil-Janssen Pharmaceuticals, Inc,
|
||
|
Att: 22
Demand Letter to The Purdue Frederick Company,
|
||
|
Att: 23
Demand Letter to Purdue Pharma Inc,
|
||
|
Att: 24
Demand Letter to Purdue Pharma L.P,
|
||
|
Att: 25
Demand Letter to Teva Pharmaceuticals USA, Inc,
|
||
|
Att: 26
Demand Letter to Watson Laboratories, Inc
|
||
| 2 | 2
CIVIL COVER SHEET. (bfa) [Transferred from med on 4/16/2019.]
|
|
| 3 | 3
CORPORATE DISCLOSURE STATEMENT by AMERISOURCEBERGEN DRUG CORPORATION. (bfa) [Transferred from med on 4/16/2019.]
|
|
| Monday, March 04, 2019 | ||
| Set Deadlines : Pro Hac Vice Certificate from MARK CHEFFO, CHARLES C. LIFLAND, DONNA WELCH, CONOR B. O'CROININ due by 3/11/2019. The Certification for Admission Pro Hac Vice form can be downloaded from our website at[LINK:http://www.med.uscourts.gov/forms] . (bfa) [Transferred from med on 4/16/2019.] | ||
| Set Deadlines : Per Local Rule 7.1 Notice of Interested Parties or Corporate Disclosure Statement from PURDUE PHARMA LP, PURDUE PHARMA INC, PURDUE FREDERICK COMPANY, TEVA PHARMACEUTICALS USA INC, CEPHALON INC, JOHNSON & JOHNSON, JANSSEN PHARMACEUTICALS INC. ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC, JANSSEN PHARMACEUTICA INC, ENDO PHARMACEUTICALS INC, ALLERGAN FINANCE LLC, WATSON LABORATORIES INC, ACTAVIS LLC, ACTAVIS PHARMA INC, ENDO HEALTH SOLUTIONS INC, INSYS THERAPEUTICS INC, MALLINCKRODT ENTERPRISES LLC, MCKESSON CORPORATION, CARDINAL HEALTH 110 LLC, CVS PHARMACY INC, WALGREENS BOOTS ALLIANCE INC WALMART INC, RITE AID CORPORATION, RITE AID OF MARYLAND INC, RITE AID OF MAINE INC due by 3/11/2019. (bfa) [Transferred from med on 4/16/2019.] | ||
| Filing Fee Paid via Credit Card ( Filing fee $ 400 receipt number 0100-1983912.), filed by AMERISOURCEBERGEN DRUG CORPORATION.(DUNLAP, JOSHUA) [Transferred from med on 4/16/2019.] | ||
| 4 | 4
CORPORATE DISCLOSURE STATEMENT by MCKESSON CORPORATION. (HANLON, MELISSA) [Transferred from med on 4/16/2019.]
|
|
| 5 | 5
LETTER sent to MDL Panel. (bfa) [Transferred from med on 4/16/2019.]
|
|
| 6 | 6
PROCEDURAL ORDER RE: REMOVAL: State Court Record due by 3/11/2019. By DEPUTY CLERK: Robert Allen. (bfa) [Transferred from med on 4/16/2019.]
|
|
| Tuesday, March 05, 2019 | ||
| 7 | 7
ACKNOWLEDGEMENT OF SERVICE Executed as to Defendants .(BELLEAU, JAMES) [Transferred from med on 4/16/2019.]
|
|
|
Att: 1
Acceptance of Service-Actavis LLC, Actavis Pharma, Cephalon, Teva, Watson Lab,
|
||
|
Att: 2
Acceptance of Service-Allergan Finance,
|
||
|
Att: 3
Acceptance of Service-AmerisourceBergen,
|
||
|
Att: 4
Acceptance of Service-Drs. Bruehl and Cieniawski,
|
||
|
Att: 5
Acceptance of Service-Cardinal,
|
||
|
Att: 6
Acceptance of Service-CVS,
|
||
|
Att: 7
Acceptance of Service-Endo Health and Endo Pharm,
|
||
|
Att: 8
Acceptance of Service-Insys,
|
||
|
Att: 9
Acceptance of Service-Janssen Pharmaceutica, Janssen Pharmaceuticals, Johnson & Johnson, Ortho-McNeil-Janssen,
|
||
|
Att: 10
Acceptance of Service-Dr. Jorgensen,
|
||
|
Att: 11
Acceptance of Service-Mallinckrodt,
|
||
|
Att: 12
Acceptance of Service-McKesson,
|
||
|
Att: 13
Acceptance of Service-Purdue Pharma Inc., Purdue Pharma LP and Purdue Frederick,
|
||
|
Att: 14
Acceptance of Service-Rite Aid Corp, Rite Aid of Maine, Rite Aid of Maryland,
|
||
|
Att: 15
Acceptance of Service-Walgreens,
|
||
|
Att: 16
Acceptance of Service-Walmart
|
||
| 8 | 8
CORPORATE DISCLOSURE STATEMENT by CVS PHARMACY INC. (SANCHEZ, GERALDINE) [Transferred from med on 4/16/2019.]
|
|
| 9 | 9
CERTIFICATION for Admission Pro Hac Vice of Conor B. O'Croinin filed by GERALDINE G. SANCHEZ on behalf of CVS PHARMACY INC (Total admission fee $ 100 receipt number 0100-1984824.) (SANCHEZ, GERALDINE) [Transferred from med on 4/16/2019.]
|
|
| Wednesday, March 06, 2019 | ||
| 10 | 10
CORPORATE DISCLOSURE STATEMENT by ENDO HEALTH SOLUTIONS INC, ENDO PHARMACEUTICALS INC. (WOLF, KAREN) [Transferred from med on 4/16/2019.]
|
|
| 11 | 11
CERTIFICATION for Admission Pro Hac Vice of Ryan Zane Watts filed by KAREN FRINK WOLF on behalf of ENDO HEALTH SOLUTIONS INC, ENDO PHARMACEUTICALS INC (Total admission fee $ 100 receipt number 0100-1985188.) (WOLF, KAREN) [Transferred from med on 4/16/2019.]
|
|
| 12 | 12
CORPORATE DISCLOSURE STATEMENT by ACTAVIS LLC, ACTAVIS PHARMA INC, CEPHALON INC, TEVA PHARMACEUTICALS USA INC, WATSON LABORATORIES INC. (GOLDMAN, JEFF) [Transferred from med on 4/16/2019.]
|
|
| 13 | 13
CORPORATE DISCLOSURE STATEMENT by MALLINCKRODT ENTERPRISES LLC. (WOODCOCK, TIMOTHY) [Transferred from med on 4/16/2019.]
|
|
| 14 | 14
CERTIFICATION for Admission Pro Hac Vice of Andrew J. O'Connor and Brien T. O'Connor filed by TIMOTHY C. WOODCOCK on behalf of MALLINCKRODT ENTERPRISES LLC (Total admission fee $ 200 receipt number 0100-1985274.)(WOODCOCK, TIMOTHY) [Transferred from med on 4/16/2019.]
|
|
|
Att: 1
Certification for Admission Pro Hac Vice - Brien T. O'Connor
|
||
| 15 | 15
NOTICE of Appearance by TIMOTHY C. WOODCOCK on behalf of MALLINCKRODT ENTERPRISES LLC (WOODCOCK, TIMOTHY) [Transferred from med on 4/16/2019.]
|
|
| 16 | 16
CERTIFICATION for Admission Pro Hac Vice of Christopher Lovrien filed by DANIEL R. MAWHINNEY on behalf of WALMART INC (Total admission fee $ 100 receipt number 0100-1985592.) (MAWHINNEY, DANIEL) [Transferred from med on 4/16/2019.]
|
|
| 17 | 17
CORPORATE DISCLOSURE STATEMENT by WALMART INC. (MAWHINNEY, DANIEL) [Transferred from med on 4/16/2019.]
|
|
| 18 | 18
CORPORATE DISCLOSURE STATEMENT by INSYS THERAPEUTICS INC. (MALONE, KELLY) [Transferred from med on 4/16/2019.]
|
|
| Thursday, March 07, 2019 | ||
| 19 | 19
NOTICE of Appearance by GERALD F. PETRUCCELLI on behalf of RITE AID CORPORATION, RITE AID OF MAINE INC, RITE AID OF MARYLAND INC (PETRUCCELLI, GERALD) [Transferred from med on 4/16/2019.]
|
|
| 20 | 20
CORPORATE DISCLOSURE STATEMENT by RITE AID CORPORATION, RITE AID OF MAINE INC, RITE AID OF MARYLAND INC. (PETRUCCELLI, GERALD) [Transferred from med on 4/16/2019.]
|
|
| 21 | 21
Consent MOTION to Extend Time to File Answer by AMERISOURCEBERGEN DRUG CORPORATION, CARDINAL HEALTH 110 LLC, MCKESSON CORPORATION Responses due by 3/28/2019. (DUNLAP, JOSHUA) [Transferred from med on 4/16/2019.]
|
|
| 22 | 22
NOTICE of Appearance by RITCHIE E. BERGER on behalf of PURDUE FREDERICK COMPANY, PURDUE PHARMA INC, PURDUE PHARMA LP (BERGER, RITCHIE) [Transferred from med on 4/16/2019.]
|
|
| 23 | 23
CORPORATE DISCLOSURE STATEMENT by PURDUE FREDERICK COMPANY, PURDUE PHARMA INC, PURDUE PHARMA LP. (BERGER, RITCHIE) [Transferred from med on 4/16/2019.]
|
|
| 24 | 24
CERTIFICATION for Admission Pro Hac Vice of Mark S. Cheffo filed by RITCHIE E. BERGER on behalf of PURDUE FREDERICK COMPANY, PURDUE PHARMA INC, PURDUE PHARMA LP (Total admission fee $ 100 receipt number 0100-1986112.) (BERGER, RITCHIE) [Transferred from med on 4/16/2019.]
|
|
| Friday, March 08, 2019 | ||
| 25 | 25 ORDER granting without objection21 Motion to Extend Time to File Response to Complaint. Time is extended for all Defendants to (1) 30 days after this Court rules on any motion to remand that might be filed, or (2) 30 days after the Judicial Panel on Multidistrict Litigation issues a final decision as to whether to transfer the case to the Multidistrict Litigation, whichever date is later. By MAGISTRATE JUDGE JOHN C. NIVISON. (NIVISON, JOHN) [Transferred from med on 4/16/2019.] | |
| 26 | 26
CERTIFICATION for Admission Pro Hac Vice of Donna M. Welch filed by SIGMUND D. SCHUTZ on behalf of ALLERGAN FINANCE LLC (Total admission fee $ 100 receipt number 0100-1986753.) (SCHUTZ, SIGMUND) [Transferred from med on 4/16/2019.]
|
|
| 27 | 27
CORPORATE DISCLOSURE STATEMENT by ALLERGAN FINANCE LLC. (SCHUTZ, SIGMUND) [Transferred from med on 4/16/2019.]
|
|
| 28 | 28
***Filed in wrong case*** NOTICE of Appearance by MICHELLE I. SCHAFFER on behalf of JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC (SCHAFFER, MICHELLE) Modified on 3/8/2019 to indicate document filed in wrong case (jgd). [Transferred from med on 4/16/2019.]
|
|
| 29 | 29
***Filed in wrong case*** CERTIFICATION for Admission Pro Hac Vice of Charles C. Lifland filed by MICHELLE I. SCHAFFER on behalf of JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC (Total admission fee $ 100 receipt number 0100-1986898.) (SCHAFFER, MICHELLE) Modified on 3/8/2019 to indicate filed in wrong case (jgd). [Transferred from med on 4/16/2019.]
|
|
| 30 | 30
***Filed in wrong case*** CORPORATE DISCLOSURE STATEMENT by JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC. (SCHAFFER, MICHELLE) Modified on 3/8/2019 to indicate filed in wrong case (jgd). [Transferred from med on 4/16/2019.]
|
|
| 31 | 31
STATE COURT RECORD with Affidavit by AMERISOURCEBERGEN DRUG CORPORATION. (DUNLAP, JOSHUA) [Transferred from med on 4/16/2019.]
|
|
| 32 | 32
NOTICE of Appearance by JAMES M. CAMPBELL on behalf of JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC (CAMPBELL, JAMES) [Transferred from med on 4/16/2019.]
|
|
| 33 | 33 NOTICE of Docket Entry Modification regarding28 Notice of Appearance,29 Certification for Admission Pro Hac Vice,30 Corporate Disclosure Statement: These docket entries have been modified to indicate the wrong document was attached. Counsel have been asked to refile. (jgd) [Transferred from med on 4/16/2019.] | |
| 34 | 34
NOTICE of Appearance by MICHELLE I. SCHAFFER on behalf of JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC (SCHAFFER, MICHELLE) [Transferred from med on 4/16/2019.]
|
|
| 35 | 35
CORPORATE DISCLOSURE STATEMENT by JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC. (SCHAFFER, MICHELLE) [Transferred from med on 4/16/2019.]
|
|
| 36 | 36
CERTIFICATION for Admission Pro Hac Vice of Charles C. Lifland filed by MICHELLE I. SCHAFFER on behalf of JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC (SCHAFFER, MICHELLE) [Transferred from med on 4/16/2019.]
|
|
| 42 | 42
ADDITIONAL ATTACHMENTS filed by AMERISOURCEBERGEN DRUG CORPORATION re31 State Court Record. Main Document: Cumberland County Superior Court Docket Record for Case PORSC-CV-2019-00019.(mnw) [Transferred from med on 4/16/2019.]
|
|
|
Att: 1
Cumberland County Superior Court Complaint,
|
||
|
Att: 2
Summary Sheet,
|
||
|
Att: 3
Exhibit 1 to Complaint: Demand Letter to Actavis LLC,
|
||
|
Att: 4
Exhibit 2 to Complaint: Demand Letter to Actavis Pharma Inc,
|
||
|
Att: 5
Exhibit 3 to Complaint: Demand Letter to Allergan PLC,
|
||
|
Att: 6
Exhibit 4 to Complaint: Demand Letter to Allergan PLC,
|
||
|
Att: 7
Exhibit 5 to Complaint : Demand Letter to AmerisourceBergen Drug Corp,
|
||
|
Att: 8
Exhibit 6 to Complaint: Demand Letter to Dr. Bruehl,
|
||
|
Att: 9
Exhibit 7 to Complaint: Demand Letter to Cardinal Health 110 LLC,
|
||
|
Att: 10
Exhibit 8 to Complaint: Demand Letter to Cephalon Inc,
|
||
|
Att: 11
Exhibit 9 to Complaint: Demand Letter to Dr. Cieniawski,
|
||
|
Att: 12
Exhibit 10 to Complaint: Demand Letter to Endo Health Solutions Inc,
|
||
|
Att: 13
Exhibit 11 to Complaint: Demand Letter to Endo Pharmaceutials Inc,
|
||
|
Att: 14
Exhibit 12 to Complaint: Demand Letter to Insys Therapeutics Inc,
|
||
|
Att: 15
Exhibit 13 to Complaint: Demand Letter to Janssen Pharmaceutica Inc,
|
||
|
Att: 16
Exhibit 14 to Complaint: Demand Letter to Janssen Pharmaceuticals Inc,
|
||
|
Att: 17
Exhibit 15 to Complaint: Demand Letter to Johnson & Johnson,
|
||
|
Att: 18
Exhibit 16 to Complaint: Demand Letter to Dr. Jorgensen,
|
||
|
Att: 19
Exhibit 17 to Complaint: Demand Letter to Mallinckrodt Enterprises LLC,
|
||
|
Att: 20
Exhibit 18 to Complaint: Demand Letter to McKesson Corp,
|
||
|
Att: 21
Exhibit 19 to Complaint: Demand Letter to Ortho-McNeil-Janssen Pharmaceuticals Inc,
|
||
|
Att: 22
Exhibit 20 to Complaint: Demand Letter to The Purdue Frederick Company,
|
||
|
Att: 23
Exhibit 21 to Complaint: Demand Letter to Purdue Pharma Inc,
|
||
|
Att: 24
Exhibit 22 to Complaint: Demand Letter to Purdue Pharma LP,
|
||
|
Att: 25
Exhibit 23 to Complaint: Demand Letter to Teva Pharmaceuticals USA Inc,
|
||
|
Att: 26
Exhibit 24 to Complaint: Demand Letter to Watson Laboratories Inc,
|
||
|
Att: 27
McKesson Corp's Assented to Motion to Extend Deadline,
|
||
|
Att: 28
Notice of Entry of Appearance Hanlon,
|
||
|
Att: 29
AmerisourceBergen Drug Corp's Consent Motion for Extension of Time,
|
||
|
Att: 30
Entry of Appearance Petruccelli,
|
||
|
Att: 31
Order granting AmerisourceBergen Drug Corp's Consent Motion,
|
||
|
Att: 32
Order Granting McKesson Corp's Assented to Motion,
|
||
|
Att: 33
Bruehl and Cieniawski's Consented to Motion to Extend Deadline,
|
||
|
Att: 34
Entry of Appearance Cahoon,
|
||
|
Att: 35
Retain Pharmacy Defendants' Assented to Motion to Extend Deadlines,
|
||
|
Att: 36
Entry of Appearance Sturtevant,
|
||
|
Att: 37
Order Granting Bruehl and Cieniawski's Consented to Motion,
|
||
|
Att: 38
Order Granting Retail Pharmacy Defendants' Assented to Motion,
|
||
|
Att: 39
AmerisourceBergen Drug Corp's Notice of Filing Notice of Removal
|
||
| Monday, March 11, 2019 | ||
| 37 | 37
CORPORATE DISCLOSURE STATEMENT by WALGREENS BOOTS ALLIANCE INC. (CAHOON, JOSEPH) [Transferred from med on 4/16/2019.]
|
|
| Wednesday, March 13, 2019 | ||
| Reset Deadlines : Per Local Rule 7.1 Notice of Interested Parties or Corporate Disclosure Statement due from CARDINAL HEALTH 110 LLC by 3/22/2019. (mnw) [Transferred from med on 4/16/2019.] | ||
| 38 | 38
NOTICE of Appearance by JOSHUA D. HADIARIS and MARK G. LAVOIE on behalf of MICHAEL B BRUEHL, MD, MARK E CIENIAWSKI, MD (HADIARIS, JOSHUA) Modified on 3/14/2019 to clean up text (mnw). [Transferred from med on 4/16/2019.]
|
|
| Thursday, March 14, 2019 | ||
| 39 | 39
CERTIFICATION for Admission Pro Hac Vice of K. Neil Austin filed by JOSHUA D. HADIARIS on behalf of MICHAEL B BRUEHL, MD, MARK E CIENIAWSKI, MD (Total admission fee $ 100 receipt number 0100-1989757.) (HADIARIS, JOSHUA) [Transferred from med on 4/16/2019.]
|
|
| 40 | 40
CERTIFICATION for Admission Pro Hac Vice of David R. Geiger filed by JOSHUA D. HADIARIS on behalf of MICHAEL B BRUEHL, MD, MARK E CIENIAWSKI, MD (Total admission fee $ 100 receipt number 0100-1989762.) (HADIARIS, JOSHUA) [Transferred from med on 4/16/2019.]
|
|
| 41 | 41
CERTIFICATION for Admission Pro Hac Vice of Ethan Severance filed by JOSHUA D. HADIARIS on behalf of MICHAEL B BRUEHL, MD, MARK E CIENIAWSKI, MD (Total admission fee $ 100 receipt number 0100-1989763.) (HADIARIS, JOSHUA) [Transferred from med on 4/16/2019.]
|
|
| Friday, March 15, 2019 | ||
| Set Deadlines : Attorney Ethan Severance shall register for the District of Maine's Electronic Case Filing (ECF) System by 3/22/2019. Registration Forms are available on the Court's website[LINK:http://www.med.uscourts.gov/ecf-registration] under the Electronic Case Files, ECF Registration Section. (mnw) [Transferred from med on 4/16/2019.] | ||
| Monday, March 25, 2019 | ||
| Reset Deadlines : Per Local Rule 7.1 Notice of Interested Parties or Corporate Disclosure Statement due from CARDINAL HEALTH 110 LLC by 4/1/2019. (mnw) [Transferred from med on 4/16/2019.] | ||
| 43 | 43
CORPORATE DISCLOSURE STATEMENT by CARDINAL HEALTH 110 LLC. (HAWKINS, CHRISTOPHER) [Transferred from med on 4/16/2019.]
|
|
| Friday, April 05, 2019 | ||
| 44 | 44
MDL ORDER LIFTING STAY OF CONDITIONAL TRANSFER ORDER (mnw) [Transferred from med on 4/16/2019.]
|
|
| Monday, April 08, 2019 | ||
| 45 | 45
MDL CERTIFIED TRANSFER ORDER LIFTING STAY OF CONDITIONAL TRANSFER ORDER. (jgd) [Transferred from med on 4/16/2019.]
|
|
| Tuesday, April 16, 2019 | ||
| 46 | 46
CASE TRANSFERRED IN from District of Maine. Case number 2:19-cv-00093. Original file, certified copy of transfer order and docket sheet received.
|
|